Photoselective vaporization of the prostate (PVP) using 80 watt high power potassium-titanyl-phosphate (KTP) laser for benign prostatic hyperplasia: The first fifty-seven patients in Japan

Japanese Journal of Urology

Volumn 97, Issue 7, 2006, Pages 815-822

  Kuromatsu, Isao ^a   Imamura, Tetsuya ^b   Sugimura, Yoshiki ^b  

^a NAGOYA CENTRAL HOSPITAL   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

BPH; KTP laser; PVP

Indexed keywords

HEMOGLOBIN; POTASSIUM DIHYDROGEN PHOSPHATE; POTASSIUM TITANYL PHOSPHATE; PROSTATE SPECIFIC ANTIGEN; SODIUM; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER IRRIGATION; BLOOD TRANSFUSION; CONTROLLED STUDY; DIAGNOSTIC TEST; FLOW RATE; HUMAN; LOW LEVEL LASER THERAPY; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RESIDUAL URINE; SCORING SYSTEM; SODIUM BLOOD LEVEL; VAPORIZATION;

EID: 33846081456     PISSN: 00215287     EISSN: None     Source Type: Journal    
DOI: 10.5980/jpnjurol1989.97.815     Document Type: Article

References (15)

1. Costello, A.J., Bowsher, W.G., Bolton, D.M., Braslis, K.G. and Burt, J.: Laser ablation of the prostate in patients with benign prostatic hypertrophy. Brit J. Urol., 69, 603-608, 1992.
2. Gilling, P.J., Cass, C.B., Malcom, A. and Fraundorfer, M.R.: Combination holmium and Nd: YAG laser ablation of the prostate: Initial clinical experience. J. Endourol., 9, 151-153, 1995.
3. Gilling, P.J., Cass, C.B., Cresswell, M.D. and Fraundorfer, M.R.: Holmium laser resection of the prostate: Preliminary results of a new method for the treatment of benign prostatic hyperplasia. Urology, 47, 48-51, 1996.
4. Fraundorfer, M.R. and Gilling, P.J.: Holmium: YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur. Urol., 33, 69-72, 1998.
5. Gilling, P.J., Kennett, K., Das, A.K., Thompson, D., and Fraundorfer, M.R.: Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience. J. Endourol., 12, 457-459, 1998.
6. Malek, R.S., Kuntzman, R.S. and Barrett, D.M.: High power potassium-titanyl-phosphate laser vaporization prostatectomy. J. Urol., 163, 1730-1733, 2000.
7. Hai, M.A. and Malek, R.S. : Photoselective vaporization of the prostate: Initial experience with a new 80W KTP laser for the treatment of benign prostatic hyperplasia. J. Endourol., 17, 93-96, 2003.
8. Malek, R.S and Nahen, K.: Photoselective vaporization of the prostate (PVP): KTP laser therapy of obstructive benign prostatic hyperplasia. AUA-Update, 23, 153-160, 2004.
9. Te, A.E., Malloy, T.R., Stein, B.S., Ulchaker, J.C., Nseyo, U.O., Hai, M.A. and Malek, R.S.: Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from The First United States Multicenter Prospective Trial. J. Urol., 172, 1404-1408, 2004.
10. Sandhu, J.S., Ng, C., Vanderbrink, B.A., Egan, C., Kaplan, S.A. and Te, A.E.: High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology, 64, 1155-1159, 2004.
11. Bachmann, A., Ruszat, R., Wyler, S., Reich, O., Seifert, H.H., Müller, A. and Sulser, T.: Photoselective vaporization of the prostate: The basel experience after 108 procedures. Eur. Urol., 48, 798-804, 2005.
12. Bachmann, A., Schurch, L., Ruszat, R., Wyler, S.F., Seifert, H.H., Muller, A., Lehmann, K. and Sulser, T.: Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): A prospective Bi-Centre study of perioperative morbidity and early functional outcome. Eur. Urology., 48, 965-972, 2005.
13. Malek, R.S., Kuntzman, R.S. and Barrett, D.M.: Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J. Urol., 174, 1344-1348, 2005.
14. Kumar, S.M.: Photoselective vaporization of the prostate: A volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate. J. Urol., 173, 511-513, 2005.
15. Reich, O., Bachmann, A., Siebels, M., Hofstetter, A., Stief, C.G. and Sulser, T.: High power (80W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J. Urol., 173, 158-160, 2005.